VIDA

VIDA Diagnostics, Inc. is a leader in lung and respiratory intelligence, developing AI-powered solutions to modernize lung care and improve patient outcomes. Their comprehensive approach focuses on both clinical practice and clinical trials, providing insights for diagnosis, treatment planning, and research. Their software is FDA cleared, CE-marked, Health Canada licensed and TGA registered for clinical use in the US, European Economic Area, Canada, and Australia.

VIDA's mission is to accelerate therapies to patients through their AI-powered lung intelligence. They offer two main solutions: VIDA Discovery, which streamlines respiratory clinical trials by providing precise endpoints, AI-powered data quality controls, and site training; and VIDA Insights, which empowers physicians to better manage patients with or at risk of chronic obstructive pulmonary disease (COPD), interstitial lung disease (ILD), asthma, emphysema, lung cancer, and COVID-19.

VIDA Diagnostics, Inc. is a precision lung health company focused on modernizing lung and respiratory care through artificial intelligence. Their mission is to accelerate therapies to patients through AI-powered lung intelligence, improving patient outcomes, streamlining care coordination, and driving efficiencies for healthcare organizations and physicians. Their solutions include VIDA Discovery, which enables more efficient respiratory clinical trials, and VIDA Insights, which empowers physicians to better manage patients with or at risk of various lung diseases.

VIDA fosters a culture of innovation, collaboration, and clinical leadership, emphasizing a dedication to improving patient outcomes and driving efficiencies in lung and respiratory care. The company embraces a dynamic and forward-thinking approach, evidenced by its commitment to AI-powered solutions, partnerships with leading healthcare organizations, and a focus on continuous product development and research.